Anti-Retroviral Agents

• 

  Subject Areas on Research

  • A Mixed Methods Approach to Understanding Antiretroviral Treatment Preferences: What Do Patients Really Want? 
  • A randomized controlled trial of a coping group intervention for adults with HIV who are AIDS bereaved: longitudinal effects on grief. 
  • Accurate Dosing of Antiretrovirals at Home Using a Foilized, Polyethylene Pouch to Prevent the Transmission of HIV From Mother to Child. 
  • Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation. 
  • Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in North Carolina. 
  • Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature. 
  • Aging of the Liver: What This Means for Patients with HIV. 
  • Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model. 
  • Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania. 
  • Antiretroviral drug resistance among treatment-naïve HIV-1-infected persons in Washington, D.C. 
  • Antiretroviral preexposure prophylaxis for HIV prevention. 
  • Antiretroviral therapy and the kidney. 
  • Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection. 
  • Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya. 
  • Antiretroviral treatment literacy among HIV voluntary counseling and testing clients in Moshi, Tanzania, 2003 to 2005. 
  • Antiretroviral treatment strategies in resource-limited settings. 
  • Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study. 
  • Association of knowledge on ART line of treatment, scarcity of treatment options and adherence. 
  • Attitudes Toward Long-Term Use of Antiretroviral Therapy Among HIV-Infected Pregnant Women in Moshi, Tanzania: A Longitudinal Study. 
  • Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. 
  • Brief report: assessing adherence to pediatric antiretroviral regimens using the 24-hour recall interview. 
  • Building resilience: a mental health intervention for Tanzanian youth living with HIV. 
  • CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy. 
  • CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States. 
  • Cardiovascular Disease and HIV: Pathophysiology, Treatment Considerations, and Nursing Implications. 
  • Caregiver self-efficacy to talk about sex predicts conversations about HIV transmission risk with perinatally infected young people in Zimbabwe. 
  • Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon. 
  • Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. 
  • Cognitive behavioral therapy for persons living with HIV in China: A randomized pilot trial. 
  • Cord blood lipids in infants born to HIV-1-infected women treated with combination antiretroviral therapy. 
  • Cost-effectiveness of free HIV voluntary counseling and testing through a community-based AIDS service organization in Northern Tanzania. 
  • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. 
  • Delaying a treatment switch in antiretroviral-treated HIV type 1-infected patients with detectable drug-resistant viremia does not have a profound effect on immune parameters: AIDS Clinical Trials Group Study A5115. 
  • Depression, ART Adherence, and Receipt of Case Management Services by Adults with HIV in North Carolina, Medical Monitoring Project, 2009-2013. 
  • Depressive Symptoms and Engagement in Human Immunodeficiency Virus Care Following Antiretroviral Therapy Initiation. 
  • Development of a coping intervention to improve traumatic stress and HIV care engagement among South African women with sexual trauma histories. 
  • Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study. 
  • Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel. 
  • Drug rechallenge following drug-induced liver injury. 
  • Effect of HAART on Brain Organization and Function in HIV-Negative Subjects. 
  • Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzee. 
  • Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study. 
  • Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. 
  • Enhancing linkage and retention in HIV care: a review of interventions for highly resourced and resource-poor settings. 
  • Epic Allies: A Gamified Mobile App to Improve Engagement in HIV Care and Antiretroviral Adherence among Young Men Who have Sex with Men. 
  • Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry? 
  • External ophthalmoplegia in human immunodeficiency virus-infected patients receiving antiretroviral therapy. 
  • Features of cardiovascular disease in low-income and middle-income countries in adults and children living with HIV. 
  • Generic and branded drugs for the treatment of people living with HIV/AIDS. 
  • Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth. 
  • HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research. 
  • HIV community viral load trends in South Carolina. 
  • HIV immune reconstitution syndrome in sub-Saharan Africa. 
  • HIV in the dialysis population: Current issues and future directions. 
  • HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment. 
  • HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. 
  • Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy. 
  • Identifying Symptom Clusters Among People Living With HIV on Antiretroviral Therapy in China: A Network Analysis. 
  • Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial. 
  • Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial. 
  • Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. 
  • Influence of HLA-C expression level on HIV control. 
  • Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. 
  • Informing the dosing of interventions in randomized trials. 
  • Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo. 
  • Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. 
  • Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS. 
  • Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi. 
  • Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. 
  • Leveraging a Landmark Trial of Primary Cardiovascular Disease Prevention in Human Immunodeficiency Virus: Introduction From the REPRIEVE Coprincipal Investigators. 
  • Lipid changes associated with antiretroviral therapy: results differ by reporting approach. 
  • Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. 
  • Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use. 
  • Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study. 
  • Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316. 
  • Modality of Primary HIV Disclosure and Association with Mental Health, Stigma, and Antiretroviral Therapy Adherence in Tanzanian Youth Living with HIV. 
  • Morbidity and mortality among a cohort of HIV-infected adults in a programme for community home-based care, in the Kilimanjaro Region of Tanzania (2003-2005). 
  • Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. 
  • NASH in HIV. 
  • Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. 
  • Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings. 
  • Ocular parameters of biological ageing in HIV-infected individuals in South Africa: relationship with chronological age and systemic biomarkers of ageing. 
  • Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. 
  • Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure. 
  • Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP. 
  • Pharmacokinetic interactions between buprenorphine and antiretroviral medications. 
  • Pharmacotherapy for human immunodeficiency virus-associated nephropathy. 
  • Postnatal cytomegalovirus exposure in infants of antiretroviral-treated and untreated HIV-infected mothers. 
  • Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. 
  • Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania. 
  • Preexposure prophylaxis for HIV infection among African women. 
  • Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. 
  • Prevalence and incidence of probable perinatal depression among women enrolled in Option B+ antenatal HIV care in Malawi. 
  • Probable antenatal depression at antiretroviral initiation and postpartum viral suppression and engagement in care. 
  • Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. 
  • Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment. 
  • Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial. 
  • Real-time updates of meta-analyses of HIV treatments supported by a biomedical ontology. 
  • Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer. 
  • Relation of lifetime trauma and depressive symptoms to mortality in HIV. 
  • Reliability, validity and measurement invariance of the Simplified Medication Adherence Questionnaire (SMAQ) among HIV-positive women in Ethiopia: a quasi-experimental study. 
  • Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa. 
  • SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques. 
  • Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients. 
  • Schizophrenia, drug therapy, and monitoring. 
  • Self-disclosure of HIV status, disclosure counseling, and retention in HIV care in Cameroon. 
  • Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4+ T Cells. 
  • Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature. 
  • The HIV-AIDS pandemic at 25--the global response. 
  • The effect of HIV infection, antiretroviral therapy on carotid intima-media thickness: A systematic review and meta-analysis. 
  • The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. 
  • The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam. 
  • The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains. 
  • The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. 
  • The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. 
  • The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. 
  • Therapeutic drug monitoring of antimycobacterial drugs in patients with both tuberculosis and advanced human immunodeficiency virus infection. 
  • Treatment of children with HIV infection. 
  • Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015. 
  • Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review. 
  • Women's perspectives on ImpACT: a coping intervention to address sexual trauma and improve HIV care engagement in Cape Town, South Africa. 
• 

  Keywords of People

  • Cunningham, Coleen Kathryn, Adjunct Professor in the Department of Pediatrics, Pediatrics
  • Murdoch, David Martin, Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine
  • Whetten, Kathryn, Professor in the Sanford School of Public Policy, School of Nursing